Manjari Lal PhD is a seasoned expert in formulation technologies for vaccines and pharmaceuticals, currently serving as Program Advisor and Portfolio Leader at PATH since July 2019. Manjari's work focuses on developing thermostable formulations tailored for low- and medium-income countries, utilizing various presentation formats such as liquid, lyophilized, and lipid nanoparticles, while adhering to ICH stability testing guidelines. Prior experience includes leadership roles at PATH, where formulation activities involved a thermo-tolerant Shigella vaccine candidate and mucosal delivery systems. Earlier positions include Research Scientist III at Sonus Pharma, concentrating on lipophilic cis-platin anti-cancer complexes, and significant research at SUNY Buffalo involving nanoparticle synthesis and characterization. Manjari holds a PhD in Chemistry from Buffalo State University, complemented by a degree from Delhi University.
This person is not in any teams
This person is not in any offices